Food and Drug Administration Safety and Innovation Act
Became Public Law No: 112-144.
SAMDT 2111 - 112
SAMDT 2111 - 112
To provide substantial savings in health care costs to the Federal government and consumers by fostering competition among generic pharmaceutical manufacturers and ensuring that anti-competitive "pay-for-delay" settlements between brand-name and generic pharmaceutical manufacturers do not block generic drugs from entering the market.
Latest action
May 24, 2012
0
actions
0
cosponsors
1
bills
0
text versions
Connected bills
Timeline
No amendment action timeline is currently available.
Cosponsors
No amendment cosponsor records are currently available.
Text Versions
No amendment text versions are currently available.
Compiled amendment record. Amendment pages combine Congress.gov source payloads, normalized relationships, action timelines, text links, and search metadata. This is not an official government record.